NATL HEALTH INVESTORS INC (NHI) Fundamental Analysis & Valuation

NYSE:NHI • US63633D1046

Current stock price

85.97 USD
+0.65 (+0.76%)
At close:
85.97 USD
0 (0%)
After Hours:

This NHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NHI Profitability Analysis

1.1 Basic Checks

  • NHI had positive earnings in the past year.
  • NHI had a positive operating cash flow in the past year.
  • Each year in the past 5 years NHI has been profitable.
  • NHI had a positive operating cash flow in each of the past 5 years.
NHI Yearly Net Income VS EBIT VS OCF VS FCFNHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • The Return On Assets of NHI (5.08%) is better than 93.50% of its industry peers.
  • NHI's Return On Equity of 9.33% is amongst the best of the industry. NHI outperforms 85.37% of its industry peers.
  • With an excellent Return On Invested Capital value of 5.56%, NHI belongs to the best of the industry, outperforming 95.12% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NHI is above the industry average of 3.13%.
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROIC 5.56%
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
NHI Yearly ROA, ROE, ROICNHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • NHI's Profit Margin of 37.80% is amongst the best of the industry. NHI outperforms 91.87% of its industry peers.
  • NHI's Profit Margin has declined in the last couple of years.
  • NHI has a Operating Margin of 50.74%. This is amongst the best in the industry. NHI outperforms 93.50% of its industry peers.
  • NHI's Operating Margin has declined in the last couple of years.
  • NHI has a Gross Margin of 80.86%. This is amongst the best in the industry. NHI outperforms 82.11% of its industry peers.
  • In the last couple of years the Gross Margin of NHI has declined.
Industry RankSector Rank
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
NHI Yearly Profit, Operating, Gross MarginsNHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NHI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NHI is destroying value.
  • Compared to 1 year ago, NHI has more shares outstanding
  • Compared to 5 years ago, NHI has more shares outstanding
  • Compared to 1 year ago, NHI has an improved debt to assets ratio.
NHI Yearly Shares OutstandingNHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NHI Yearly Total Debt VS Total AssetsNHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.13 indicates that NHI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of NHI (2.13) is better than 95.94% of its industry peers.
  • A Debt/Equity ratio of 0.76 indicates that NHI is somewhat dependend on debt financing.
  • NHI has a Debt to Equity ratio of 0.76. This is in the better half of the industry: NHI outperforms 74.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 2.13
ROIC/WACC0.72
WACC7.76%
NHI Yearly LT Debt VS Equity VS FCFNHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • NHI has a Current Ratio of 1.19. This is a normal value and indicates that NHI is financially healthy and should not expect problems in meeting its short term obligations.
  • NHI has a better Current ratio (1.19) than 64.23% of its industry peers.
  • A Quick Ratio of 1.19 indicates that NHI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.19, NHI is in the better half of the industry, outperforming 65.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
NHI Yearly Current Assets VS Current LiabilitesNHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. NHI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.34% over the past year.
  • The Earnings Per Share has been decreasing by -6.07% on average over the past years.
  • The Revenue has grown by 12.07% in the past year. This is quite good.
  • NHI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.45% yearly.
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.48% on average over the next years.
  • NHI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.69% yearly.
EPS Next Y10.03%
EPS Next 2Y7.73%
EPS Next 3Y6.48%
EPS Next 5YN/A
Revenue Next Year21.74%
Revenue Next 2Y15.72%
Revenue Next 3Y16.68%
Revenue Next 5Y14.69%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NHI Yearly Revenue VS EstimatesNHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
NHI Yearly EPS VS EstimatesNHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. NHI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.47, the valuation of NHI can be described as expensive.
  • Based on the Price/Earnings ratio, NHI is valued a bit cheaper than the industry average as 69.92% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of NHI to the average of the S&P500 Index (27.53), we can say NHI is valued inline with the index average.
  • A Price/Forward Earnings ratio of 25.87 indicates a quite expensive valuation of NHI.
  • Based on the Price/Forward Earnings ratio, NHI is valued cheaply inside the industry as 86.18% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 37.95. NHI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 28.47
Fwd PE 25.87
NHI Price Earnings VS Forward Price EarningsNHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NHI is valued a bit more expensive than the industry average as 78.86% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.56
NHI Per share dataNHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NHI does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of NHI may justify a higher PE ratio.
PEG (NY)2.84
PEG (5Y)N/A
EPS Next 2Y7.73%
EPS Next 3Y6.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NHI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.27%, NHI is a good candidate for dividend investing.
  • NHI's Dividend Yield is comparable with the industry average which is at 7.71.
  • NHI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.27%

5.2 History

  • The dividend of NHI decreases each year by -3.59%.
  • NHI has paid a dividend for at least 10 years, which is a reliable track record.
  • NHI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-3.59%
Div Incr Years1
Div Non Decr Years3
NHI Yearly Dividends per shareNHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • 119.52% of the earnings are spent on dividend by NHI. This is not a sustainable payout ratio.
DP119.52%
EPS Next 2Y7.73%
EPS Next 3Y6.48%
NHI Yearly Income VS Free CF VS DividendNHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M
NHI Dividend Payout.NHI Dividend Payout, showing the Payout Ratio.NHI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NHI Fundamentals: All Metrics, Ratios and Statistics

NATL HEALTH INVESTORS INC

NYSE:NHI (4/16/2026, 8:04:00 PM)

After market: 85.97 0 (0%)

85.97

+0.65 (+0.76%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners73.55%
Inst Owner Change0.01%
Ins Owners0.99%
Ins Owner Change14.59%
Market Cap4.17B
Revenue(TTM)375.63M
Net Income(TTM)141.98M
Analysts76.67
Price Target91.16 (6.04%)
Short Float %3.59%
Short Ratio5.28
Dividend
Industry RankSector Rank
Dividend Yield 4.27%
Yearly Dividend3.61
Dividend Growth(5Y)-3.59%
DP119.52%
Div Incr Years1
Div Non Decr Years3
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.1%
Min EPS beat(2)-8.3%
Max EPS beat(2)-1.91%
EPS beat(4)1
Avg EPS beat(4)-1.5%
Min EPS beat(4)-8.3%
Max EPS beat(4)4.29%
EPS beat(8)4
Avg EPS beat(8)0.17%
EPS beat(12)6
Avg EPS beat(12)2.26%
EPS beat(16)7
Avg EPS beat(16)-10.94%
Revenue beat(2)2
Avg Revenue beat(2)8.55%
Min Revenue beat(2)5.78%
Max Revenue beat(2)11.32%
Revenue beat(4)4
Avg Revenue beat(4)6.17%
Min Revenue beat(4)3.26%
Max Revenue beat(4)11.32%
Revenue beat(8)8
Avg Revenue beat(8)5.58%
Revenue beat(12)11
Avg Revenue beat(12)4.1%
Revenue beat(16)12
Avg Revenue beat(16)1.1%
PT rev (1m)4.38%
PT rev (3m)3.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.4%
EPS NY rev (1m)-1.35%
EPS NY rev (3m)0.38%
Revenue NQ rev (1m)3.19%
Revenue NQ rev (3m)7.65%
Revenue NY rev (1m)3.31%
Revenue NY rev (3m)9.22%
Valuation
Industry RankSector Rank
PE 28.47
Fwd PE 25.87
P/S 11.09
P/FCF N/A
P/OCF 17.61
P/B 2.74
P/tB 2.74
EV/EBITDA 19.56
EPS(TTM)3.02
EY3.51%
EPS(NY)3.32
Fwd EY3.87%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)4.88
OCFY5.68%
SpS7.75
BVpS31.4
TBVpS31.4
PEG (NY)2.84
PEG (5Y)N/A
Graham Number46.1897 (-46.27%)
Profitability
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROCE 7.04%
ROIC 5.56%
ROICexc 5.6%
ROICexgc 5.62%
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
FCFM N/A
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
ROICexc(3y)5.81%
ROICexc(5y)5.5%
ROICexgc(3y)5.84%
ROICexgc(5y)5.53%
ROCE(3y)7.29%
ROCE(5y)6.89%
ROICexgc growth 3Y6.24%
ROICexgc growth 5Y-1.2%
ROICexc growth 3Y6.24%
ROICexc growth 5Y-1.17%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA 4.29
Cap/Depr 363.26%
Cap/Sales 78.28%
Interest Coverage 3.7
Cash Conversion 87.12%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 2.13
F-Score5
WACC7.76%
ROIC/WACC0.72
Cap/Depr(3y)218.38%
Cap/Depr(5y)144.44%
Cap/Sales(3y)46.96%
Cap/Sales(5y)31.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
EPS Next Y10.03%
EPS Next 2Y7.73%
EPS Next 3Y6.48%
EPS Next 5YN/A
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%
Revenue Next Year21.74%
Revenue Next 2Y15.72%
Revenue Next 3Y16.68%
Revenue Next 5Y14.69%
EBIT growth 1Y1.11%
EBIT growth 3Y10%
EBIT growth 5Y-3.26%
EBIT Next Year54.77%
EBIT Next 3Y19.24%
EBIT Next 5YN/A
FCF growth 1Y-215.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.86%
OCF growth 3Y8.48%
OCF growth 5Y0.38%

NATL HEALTH INVESTORS INC / NHI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NATL HEALTH INVESTORS INC (NHI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NHI.


What is the valuation status for NHI stock?

ChartMill assigns a valuation rating of 3 / 10 to NATL HEALTH INVESTORS INC (NHI). This can be considered as Overvalued.


What is the profitability of NHI stock?

NATL HEALTH INVESTORS INC (NHI) has a profitability rating of 7 / 10.


Can you provide the financial health for NHI stock?

The financial health rating of NATL HEALTH INVESTORS INC (NHI) is 4 / 10.


Can you provide the dividend sustainability for NHI stock?

The dividend rating of NATL HEALTH INVESTORS INC (NHI) is 5 / 10 and the dividend payout ratio is 119.52%.